GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
This Quarter Return
-13.61%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$2.03B
AUM Growth
+$2.03B
(-22%)
Cap. Flow
-$285M
Cap. Flow
% of AUM
-14.01%
Top 10 Holdings %
Top 10 Hldgs %
6.46%
Holding
2,297
New
384
Increased
672
Reduced
639
Closed
591
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$14.2M |
| 2 |
Macy's
M
|
$14M |
| 3 |
AGN
Allergan plc
AGN
|
$13.8M |
| 4 |
AbbVie
ABBV
|
$13.4M |
| 5 |
Baxter International
BAX
|
$10.9M |
Top Sells
| 1 |
Micron Technology
MU
|
$13.4M |
| 2 |
Oracle
ORCL
|
$13M |
| 3 |
Union Pacific
UNP
|
$11.4M |
| 4 |
RTN
Raytheon Company
RTN
|
$11.2M |
| 5 |
Lowe's Companies
LOW
|
$11M |
Sector Composition
| 1 | Healthcare | 22.57% |
| 2 | Consumer Discretionary | 14.52% |
| 3 | Technology | 10.02% |
| 4 | Industrials | 9.9% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Macy's
M
$3.59B
| $17M | 0.84% | 331,109 +273,732 | +477% | +$14M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $16.7M | 0.82% | 154,734 +131,027 | +553% | +$14.2M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $16.4M | 0.8% | 60,195 +50,779 | +539% | +$13.8M |
|
|
4
AbbVie
ABBV
$372B
| $15.9M | 0.78% | 291,714 +245,495 | +531% | +$13.4M |
|
5
Bausch Health
BHC
$2.74B
| $12M | 0.59% | 67,085 +28,186 | +72% | +$5.03M |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $11.1M | 0.55% | 173,361 +132,583 | +325% | +$8.48M |
|
|
7
Baxter International
BAX
$12.7B
| $10.9M | 0.54% | +331,369 | New | +$10.9M |
|
8
Sherwin-Williams
SHW
$91.2B
| $10.6M | 0.52% | 47,494 +39,141 | +469% | +$8.72M |
|
9
Alphabet (Google) Class C
GOOG
$2.58T
| $10.4M | 0.51% | 16,486 +12,473 | +311% | +$7.89M |
|
10
Amgen
AMGN
$155B
| $10.4M | 0.51% | 75,245 +43,194 | +135% | +$5.97M |
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $9.72M | 0.48% | 92,332 +66,366 | +256% | +$6.99M |
|
|
PARA
12
DELISTED
Paramount Global Class B
PARA
| $9.48M | 0.47% | 237,553 +100,981 | +74% | +$4.03M |
|
13
Gilead Sciences
GILD
$140B
| $9.16M | 0.45% | 93,310 +21,447 | +30% | +$2.11M |
|
14
HCA Healthcare
HCA
$94.5B
| $8.87M | 0.44% | 114,629 +71,608 | +166% | +$5.54M |
|
15
Meta Platforms (Facebook)
META
$1.86T
| $8.82M | 0.43% | +98,119 | New | +$8.82M |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $8.42M | 0.41% | 53,835 +50,750 | +1,645% | +$7.94M |
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.29M | 0.41% | 17,825 +8,666 | +95% | +$4.03M |
|
18
Viatris
VTRS
$12.3B
| $8.13M | 0.4% | 201,961 -125,066 | -38% | -$5.04M |
|
19
Wynn Resorts
WYNN
$13.2B
| $8.08M | 0.4% | 152,170 +141,200 | +1,287% | +$7.5M |
|
20
Jazz Pharmaceuticals
JAZZ
$7.75B
| $7.83M | 0.39% | 58,975 +50,564 | +601% | +$6.72M |
|
21
Illumina
ILMN
$15.8B
| $7.8M | 0.38% | 44,344 +38,366 | +642% | +$6.75M |
|
22
Biogen
BIIB
$19.4B
| $7.38M | 0.36% | 25,292 +17,620 | +230% | +$5.14M |
|
23
CF Industries
CF
$14B
| $7.12M | 0.35% | 158,648 +147,281 | +1,296% | +$6.61M |
|
24
Booking.com
BKNG
$181B
| $6.78M | 0.33% | 5,485 +5,224 | +2,002% | +$6.46M |
|
25
Qorvo
QRVO
$8.4B
| $6.51M | 0.32% | +144,393 | New | +$6.51M |
|